Phreesia, Inc. PHR
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Phreesia, Inc. is a healthcare technology company that provides a cloud-based patient intake, registration, and engagement platform for healthcare organizations. The company operates primarily within the digital health and healthcare IT industries, offering software and workflow automation tools that support administrative efficiency, patient communication, and revenue cycle optimization for medical providers. Its platform is used by physician practices, health systems, and specialty care providers to streamline patient check-in, insurance verification, consent management, appointment scheduling, payments, and post-visit engagement. Revenue is generated primarily through subscription-based software services, payment processing, and digital engagement solutions.
The company was founded in 2005 and evolved from a patient self-service kiosk provider into a broader SaaS-based healthcare engagement platform. Over time, Phreesia expanded its capabilities through internal development and acquisitions, adding patient communications, clinical screening tools, and life sciences engagement products. The company’s strategic positioning is tied to its scale in ambulatory care workflows, integration with electronic health record systems, and its ability to combine administrative automation with patient engagement and data-driven outreach.
Business Operations
Phreesia organizes its operations around integrated patient engagement and healthcare workflow solutions delivered through a unified cloud platform. Its primary business activities include subscription and service revenue from healthcare providers using its intake and engagement software, as well as payment processing revenue tied to patient financial transactions. The company also operates digital engagement and outreach services that enable healthcare and pharmaceutical organizations to communicate educational content, surveys, and adherence messaging to patients. Key operational capabilities include appointment management, mobile registration, patient payments, referral intake, clinical questionnaires, and analytics tools.
The company primarily operates in the United States, where it serves thousands of healthcare organizations across ambulatory specialties and multi-site provider networks. Phreesia maintains integrations with major electronic health record vendors and healthcare IT ecosystems, which supports interoperability and provider adoption. Strategic acquisitions have included Medfusion, a patient communication platform, and Insignia Health, known for patient activation and engagement tools. These acquisitions expanded Phreesia’s communication, patient activation, and digital engagement capabilities within the broader healthcare delivery ecosystem.
Strategic Position & Investments
Phreesia’s strategic direction centers on expanding patient engagement across the full healthcare journey while increasing automation for providers and enhancing monetization opportunities through data-enabled communication tools. The company has invested heavily in platform expansion, mobile patient access, analytics, and workflow automation. Growth initiatives have focused on increasing penetration among large provider organizations, expanding specialty care adoption, and enhancing life sciences engagement offerings that connect pharmaceutical companies with patients and providers through educational and awareness campaigns.
The company has also pursued strategic acquisitions to strengthen its market position and broaden its product portfolio. The acquisitions of Medfusion and Insignia Health added digital communication infrastructure and behavioral engagement capabilities, respectively. Phreesia continues to invest in artificial intelligence-enabled workflow enhancements, patient messaging optimization, and interoperability initiatives designed to improve operational efficiency and patient conversion rates. Its positioning within ambulatory healthcare technology is supported by recurring SaaS revenue, extensive provider integrations, and a large patient interaction network.
Geographic Footprint
Phreesia is headquartered in Wilmington, Delaware, with operational and corporate offices in multiple locations across the United States. The company’s core market presence is concentrated in the U.S. healthcare sector, particularly among ambulatory care providers, physician groups, and health systems. Its technology platform supports patient interactions across a broad range of medical specialties and healthcare delivery environments nationwide.
Although the company’s primary commercial focus remains domestic, its digital platform architecture and cloud-based services provide operational scalability and support for distributed healthcare organizations. Phreesia’s influence extends indirectly through partnerships with healthcare technology vendors, integrated delivery networks, and pharmaceutical engagement initiatives that operate across broader healthcare markets. Public filings and company disclosures indicate limited direct international operational exposure relative to its U.S.-centered business model.
Leadership & Governance
Phreesia was co-founded by healthcare technology entrepreneurs focused on improving patient-provider interactions through automation and digital engagement. The company is publicly traded on the New York Stock Exchange under the ticker PHR and operates under a governance structure typical of publicly listed healthcare technology companies. Leadership strategy has emphasized long-term platform development, recurring revenue growth, interoperability with healthcare systems, and expansion of patient engagement capabilities across the care continuum.
Key members of the leadership team include:
- Chaim Indig – Chief Executive Officer and Co-Founder
- Evan Roberts – Chief Operating Officer and Co-Founder
- Balaji Gandhi – Chief Financial Officer
- Allison Hoffman – Chief People Officer
- David Linetsky – Chief Technology Officer
- Tom Altman – General Counsel and Secretary
The company’s leadership has consistently communicated a strategy focused on modernizing patient access, improving healthcare administrative efficiency, and leveraging digital engagement tools to create value for providers, patients, and healthcare industry stakeholders.